Los puntos clave no están disponibles para este artículo en este momento.
Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed
Lin et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: